Pharma APIs, once a sleepy sector, is the flavour of the season8 min read . Updated: 10 Aug 2021, 01:23 AM IST
- India’s active pharmaceutical ingredient (API) business has been catapulted from pariah to private equity darling.
- The Indian pharma industry seems to be at yet another major inflection point. In the last 12 years, the API industry has never received so much interest from investors as it does today.
MUMBAI : Late last year, an old Mumbai-based business family set the ball rolling on a process to find an appropriate buyer who could take over a minority stake held by a private equity (PE) investor in its decade-old active pharmaceutical ingredient (API) business. There was a lot of interest from a slew of PE firms. And it wasn’t just for the minority stake. Some funds wanted to take over the entire business lock, stock, and barrel.
Select your Category